Listen: George Scangos’ retirement, annual Covid vaccines, an Alzheimer’s drug rejection

Who needs an annual Covid jab? Why did the FDA reject an Alzheimer’s treatment? And what’s in store for one of biotech’s most highly respected executives now that he’s stepping back from his CEO role?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. George Scangos, the CEO of Vir Biotechnology, joins us to discuss his retirement and offer some perspective and lessons from a remarkable, 40-year career in biotech. We also chat about the latest news in the life sciences, including an FDA advisory meeting debating the necessity for annual Covid vaccinations, and a surprising, but perhaps not, rejection of Eli Lilly’s Alzheimer’s disease treatment.

Read the rest…

Read Original Article: Listen: George Scangos’ retirement, annual Covid vaccines, an Alzheimer’s drug rejection »